This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Mark S. Litwin, MD, MPH; Ron D. Hays, PhD; Arlene Fink, PhD; Patricia A. Ganz, MD; Barbara Leake, PhD; Gary E. Leach, MD; Robert H. Brook, MD, ScD

JAMA. 1995;273(2):129-135.

Abstract
Objective.
—To assess health-related quality of life (HRQOL) in men treated for clinically localized prostate cancer.

Design.
—A cross-sectional analysis of HRQOL after treatment with radical prostatectomy, pelvic irradiation, or observation alone for clinically localized prostatic adenocarcinoma, and in age-matched comparison patients.

Setting.
—A large managed care population in California.

Subjects.
—A total of 528 men, including 214 treated for clinically localized prostate cancer (41 with evidence of metastatic disease were excluded from this analysis) and 273 age-matched, ZIP code—matched comparison patients without prostate cancer. Cancer patients were analyzed in three treatment groups: radical prostatectomy (n=98), primary pelvic irradiation (n=56), and observation alone (n=60).

Main Outcome Measures.
—General HRQOL was measured with the RAND 36-Item Health Survey 1.0. Cancer-specific HRQOL was measured with the CAncer Rehabilitation Evaluation System—Short Form and the Functional Assessment of Cancer Therapy—General form. Disease-targeted quality of life was measured with a new instrument assessing function and bother in three organ systems: sexual, urinary, and bowel.

Results.
—No differences among treatment groups were seen in comparisons of general HRQOL. Significant differences among treatment groups were seen in both function and bother in the prostate-targeted measures of sexual, urinary, and bowel domains. When cancer patients were compared with men of similar age without prostate cancer, differences were seen in the sexual, urinary, and bowel function and bother but not in general HRQOL measures. Although cancer-free men were found not to have full potency or continence, prostate cancer patients treated with surgery or radiation reported significantly worse sexual, urinary, and bowel function than men without cancer. Men who had undergone nerve-sparing prostatectomy did not differ from those who had undergone standard prostatectomy, but the power to detect a difference was low.

Conclusions.
—Although no differences were seen in general HRQOL, three disease-targeted domains were found to differ significantly among the treatment groups and comparison patients. Even after controlling for the sexual and urinary dysfunction experienced by older men without cancer, those receiving therapeutic interventions for their prostate cancer were found to have poorer disease-targeted HRQOL. We conclude that in addition to general HRQOL, disease-targeted measures must be used to assess outcomes of care in men treated for localized prostate cancer.

(JAMA. 1995;273:129-135)

Author Affiliations
From the Divisions of Urology (Dr Litwin), General Internal Medicine (Drs Fink, Hays, and Leake), and Geriatrics (Dr Brook), UCLA School of Medicine, and the Department of Health Services, School of Public Health (Drs Litwin, Fink, Ganz, and Brook), University of California, Los Angeles; RAND Health Science Program, Santa Monica, Calif (Drs Litwin, Hays, and Brook); and the Southern California Permanente Medical Group, Los Angeles (Dr Leach).

Footnotes
The views and opinions expressed herein are those of the authors and do not necessarily reflect those of their institutions or of the Robert Wood Johnson Foundation.

Reprint requests to the Division of Urology, UCLA School of Medicine, Los Angeles, 10833 Le Conte Ave, Los Angeles, CA 90024-1738 (Dr Litwin).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A 64-Year-Old Man With Low-Risk Prostate Cancer: Review of Prostate Cancer Treatment
Sanda and Kaplan
JAMA 2009;301:2141-2151.
ABSTRACT | FULL TEXT  

Lack of Comprehension of Common Prostate Cancer Terms in an Underserved Population
Kilbridge et al.
JCO 2009;27:2015-2021.
ABSTRACT | FULL TEXT  

What is needed for informed decisions about prostate cancer screening: perspectives of African-American and Hispanic men
McFall et al.
Health Educ Res 2009;24:280-291.
ABSTRACT | FULL TEXT  

Variations in Quality of Care for Men With Early-Stage Prostate Cancer
Spencer et al.
JCO 2008;26:3735-3742.
ABSTRACT | FULL TEXT  

Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda et al.
NEJM 2008;358:1250-1261.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life Results in Pathologic Stage C Prostate Cancer From a Southwest Oncology Group Trial Comparing Radical Prostatectomy Alone With Radical Prostatectomy Plus Radiation Therapy
Moinpour et al.
JCO 2008;26:112-120.
ABSTRACT | FULL TEXT  

Prostate Cancer Quality of Life: Beyond Initial Treatment and the Patient
Talcott
JCO 2007;25:4155-4156.
FULL TEXT  

Personal Digital Assistant Data Capture: The Future of Quality of Life Measurement in Prostate Cancer Treatment
Matthew et al.
J Oncol Pract 2007;3:115-120.
ABSTRACT | FULL TEXT  

A Review and Meta-Analysis of Prostate Cancer Utilities
Bremner et al.
Med Decis Making 2007;27:288-298.
ABSTRACT  

Toward the Optimal Use of Androgen Suppression Therapy in the Radiotherapeutic Management of Prostate Cancer
D'Amico
JCO 2007;25:8-9.
FULL TEXT  

Treating Older Men With Prostate Cancer: Survival (or Selection) of the Fittest?
Litwin and Miller
JAMA 2006;296:2733-2734.
FULL TEXT  

Family History, Perceived Risk, and Prostate Cancer Screening among African American Men.
Bloom et al.
Cancer Epidemiol. Biomarkers Prev. 2006;15:2167-2173.
ABSTRACT | FULL TEXT  

Assessing Anxiety in Men With Prostate Cancer: Further Data on the Reliability and Validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC)
Roth et al.
Psychosomatics 2006;47:340-347.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life after Intensity Modulated Radiation Therapy for Localized Prostate Cancer: Comparison with Conventional and Conformal Radiotherapy
Namiki et al.
Jpn J Clin Oncol 2006;36:224-230.
ABSTRACT | FULL TEXT  

Quality-of-Life Assessment in Pediatric Brain Tumor Patients and Survivors: Lessons Learned and Challenges to Face
Tao and Parsons
JCO 2005;23:5424-5426.
FULL TEXT  

Employment After Therapy for Localized Prostate Cancer: Widening the Perspective
Talcott
JNCI J Natl Cancer Inst 2005;97:948-949.
FULL TEXT  

Achieving Optimal Outcomes After Radical Prostatectomy
Saranchuk et al.
JCO 2005;23:4146-4151.
ABSTRACT | FULL TEXT  

Long-Term Outcomes Among Localized Prostate Cancer Survivors: Health-Related Quality-of-Life Changes After Radical Prostatectomy, External Radiation, and Brachytherapy
Miller et al.
JCO 2005;23:2772-2780.
ABSTRACT | FULL TEXT  

The significance of skeletal-related events for the health-related quality of life of patients with metastatic prostate cancer
Weinfurt et al.
Ann Oncol 2005;16:579-584.
ABSTRACT | FULL TEXT  

The BCPT Symptom Scales: A Measure of Physical Symptoms for Women Diagnosed With or at Risk for Breast Cancer
Stanton et al.
JNCI J Natl Cancer Inst 2005;97:448-456.
ABSTRACT | FULL TEXT  

Racial/Ethnic Differences in Functional Outcomes in the 5 Years After Diagnosis of Localized Prostate Cancer
Johnson et al.
JCO 2004;22:4193-4201.
ABSTRACT | FULL TEXT  

Health-Related Quality of Life, Satisfaction, and Economic Outcome Measures in Studies of Prostate Cancer Screening and Treatment, 1990-2000
McNaughton-Collins et al.
J Natl Cancer Inst Monogr 2004;2004:78-101.
ABSTRACT | FULL TEXT  

A Health Outcomes Framework for Assessing Health Status and Quality of Life: Enhanced Data for Decision Making
Erickson
J Natl Cancer Inst Monogr 2004;2004:168-177.
ABSTRACT | FULL TEXT  

Burden of Illness in Cancer Survivors: Findings From a Population-Based National Sample
Yabroff et al.
JNCI J Natl Cancer Inst 2004;96:1322-1330.
ABSTRACT | FULL TEXT  

Natural History of Early, Localized Prostate Cancer
Johansson et al.
JAMA 2004;291:2713-2719.
ABSTRACT | FULL TEXT  

Quality of Life Among Disease-Free Survivors of Rectal Cancer
Rauch et al.
JCO 2004;22:354-360.
ABSTRACT | FULL TEXT  

Time Course and Predictors of Symptoms After Primary Prostate Cancer Therapy
Talcott et al.
JCO 2003;21:3979-3986.
ABSTRACT | FULL TEXT  

Patients' Perceptions of Quality of Life After Treatment for Early Prostate Cancer
Clark et al.
JCO 2003;21:3777-3784.
ABSTRACT | FULL TEXT  

Quality of Care in Prostate Cancer: Important to Start and Too Important to Stop Here
Talcott
JCO 2003;21:1902-1903.
FULL TEXT  

Quality-of-Care Indicators for Early-Stage Prostate Cancer
Spencer et al.
JCO 2003;21:1928-1936.
ABSTRACT | FULL TEXT  

General Quality of Life 2 Years Following Treatment for Prostate Cancer: What Influences Outcomes? Results From the Prostate Cancer Outcomes Study
Penson et al.
JCO 2003;21:1147-1154.
ABSTRACT | FULL TEXT  

Trends in prostate cancer incidence and mortality: an analysis of mortality change by screening intensity
Coldman et al.
CMAJ 2003;168:31-35.
ABSTRACT | FULL TEXT  

A Framework for Improving the Quality of Cancer Care: The Case of Breast and Cervical Cancer Screening
Zapka et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:4-13.
ABSTRACT | FULL TEXT  

Cancer Survivors in the United States: Age, Health, and Disability
Hewitt et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2003;58:M82-91.
ABSTRACT | FULL TEXT  

Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
Harris and Lohr
ANN INTERN MED 2002;137:917-929.
ABSTRACT | FULL TEXT  

Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)
Clarke et al.
Med Decis Making 2002;22:340-349.
ABSTRACT  

Understanding and Appreciating Overdiagnosis in the PSA Era
Yao and Lu-Yao
JNCI J Natl Cancer Inst 2002;94:958-960.
FULL TEXT  

Quality of Life After Prostate Cancer Treatment
Lee et al.
JCO 2002;20:3038-3039.
FULL TEXT  

Comparing the Costs of Radiation Therapy and Radical Prostatectomy for the Initial Treatment of Early-Stage Prostate Cancer
Burkhardt et al.
JCO 2002;20:2869-2875.
ABSTRACT | FULL TEXT  

Sexual Dysfunction and the Preservation of Manhood: Experiences of Men with Prostate Cancer
Fergus et al.
J Health Psychol 2002;7:303-316.
ABSTRACT  

Androgen Deprivation as Primary Treatment for Early Prostate Cancer: Should We "Just Do Something"?
Talcott
JNCI J Natl Cancer Inst 2002;94:407-409.
FULL TEXT  

Comprehensive Comparison of Health-Related Quality of Life After Contemporary Therapies for Localized Prostate Cancer
Wei et al.
JCO 2002;20:557-566.
ABSTRACT | FULL TEXT  

Health Outcomes After External-Beam Radiation Therapy for Clinically Localized Prostate Cancer: Results From the Prostate Cancer Outcomes Study
Hamilton et al.
JCO 2001;19:2517-2526.
ABSTRACT | FULL TEXT  

Prostate Cancer: The Price of Early Detection
Ganz and Litwin
JCO 2001;19:1587-1588.
FULL TEXT  

Prostate Cancer Gene Therapy: Comparison of Adenovirus-mediated Expression of Interleukin 12 with Interleukin 12 plus B7-1 for in Situ Gene Therapy and Gene-modified, Cell-based Vaccines
Hull et al.
Clin. Cancer Res. 2000;6:4101-4109.
ABSTRACT | FULL TEXT  

Managing Menopausal Symptoms in Breast Cancer Survivors: Results of a Randomized Controlled Trial
Ganz et al.
JNCI J Natl Cancer Inst 2000;92:1054-1064.
ABSTRACT | FULL TEXT  

Urinary and Sexual Function After Radical Prostatectomy for Clinically Localized Prostate Cancer: The Prostate Cancer Outcomes Study
Stanford et al.
JAMA 2000;283:354-360.
ABSTRACT | FULL TEXT  

Prostate Cancer Practice Patterns and Quality of Life: the Prostate Cancer Outcomes Study
Potosky et al.
JNCI J Natl Cancer Inst 1999;91:1719-1724.
FULL TEXT  

Accuracy of Recall in Health-Related Quality-of-Life Assessment Among Men Treated for Prostate Cancer
Litwin and McGuigan
JCO 1999;17:2882-2882.
ABSTRACT | FULL TEXT  

Carrier testing of children for two X linked diseases in a family based setting: a retrospective long term psychosocial evaluation
Järvinen et al.
J. Med. Genet. 1999;36:615-620.
ABSTRACT | FULL TEXT  

Dilemmas in treating early prostate cancer: the evidence and a questionnaire survey of consultant urologists in the United Kingdom
Donovan et al.
BMJ 1999;318:299-300.
FULL TEXT  

Trends in Radical Prostatectomy in New York State
Imperato et al.
American Journal of Medical Quality 1996;11:205-213.
ABSTRACT  

Health System Reform and Quality
Brook et al.
JAMA 1996;276:476-480.
ABSTRACT  

Incidence of Prostate Cancer Diagnosis in the Eras Before and After Serum Prostate-Specific Antigen Testing
Jacobsen et al.
JAMA 1995;274:1445-1449.
ABSTRACT  

Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer
Albertsen et al.
JAMA 1995;274:626-631.
ABSTRACT  

Medicine--Molecular, Monetary, or More Than Both?
Eisenberg
JAMA 1995;274:331-334.
ABSTRACT  

Informed Consent for Tests for Prostate Cancer
Marshall
JAMA 1995;274:127-128.
ABSTRACT  

A 72-Year-Old Man With Localized Prostate Cancer
Albertsen
JAMA 1995;274:69-74.
ABSTRACT  

Urology
Litwin
JAMA 1995;273:1725-1726.
ABSTRACT